We hypothesize that elevating NAD+ levels during reprogramming lowers stochastic heterochromatin noise by activating SIRT1 and SIRT6, which promotes erasure of repressive marks and facilitates a more uniform transition to pluripotency. NAD+ serves as a cofactor for sirtuin deacetylases; SIRT1 deacetylates H3K9ac and H3K56ac, weakening HP1 binding and allowing chromatin relaxation, while SIRT6 promotes H3K9 demethylation and interacts with TET enzymes to drive DNA demethylation at late-replicating domains. By decreasing cell-to-cell variance in H3K9me3 and DNA methylation, NAD+ supplementation should sharpen the epigenetic landscape, reduce noisy intermediates, and increase the fraction of iPSCs that achieve complete reset.

To test this, we will reprogram human fibroblasts from aged donors using OSKM factors in parallel cultures treated with either nicotinamide riboside (NR) or vehicle control. At 0, 24, 48, 72, and 96 hours we will collect cells for single-cell ATAC-seq, single-cell bisulfite sequencing (scBS-seq), and CUT&Tag for H3K9me3. Noise will be quantified as the variance in accessibility at a set of pluripotency‑enhancer regions (e.g., distal Oct4 enhancers) and as the dispersion of methylation percentages at CpG islands within late‑replicating heterochromatin. We will also measure OCT4 ChIP‑seq signal and expression of pluripotency markers (NANOG, SSEA4) by flow cytometry.

Predictions: NR‑treated cultures will show a significant reduction (p<0.01, effect size >0.5) in accessibility and methylation variance compared with controls, accompanied by a >2‑fold increas

Hypothesis

Circular ANRIL (circANRIL) transcripts, generated from the 9p21.3 locus, act as molecular sponges that sequester the histone demethylase Jmjd3 and specific microRNAs, thereby modulating the balance between H3K27me3 deposition and removal at the CDKN2A/B promoter in a tissue‑dependent manner. This mechanism explains why blood shows a straightforward age‑related increase in p16^INK4a expression while Alzheimer’s brain exhibits reduced CDKN2A transcription despite elevated exon‑2 CpG methylation.

Mechanistic rationale

1. circANRIL biogenesis rises with epigenetic disorder – Within‑read methylation variability (RD) at PRC2 targets increases quadratically with age [4]. Elevated RD promotes alternative splicing and backsplicing, favoring circANRIL production over linear ANRIL.
2. circANRIL binds Jmjd3 via exposed KDM6 domains – The circular structure preserves RNA‑protein interaction motifs that are obscured in linear ANRIL. By sequestering Jmjd3, circANRIL limits H3K27me3 demethylation, reinforcing PRC2‑mediated repression.
3. circANRIL also sponges miR‑204 and miR‑199a‑3p – These microRNAs normally target Jmjd3 mRNA for degradation. Their sequestration stabilizes Jmjd3 protein levels, creating a buffered system where changes in disorder translate into modest, tissue‑specific shifts in demethylase activity.
4. Tissue‑specific expression of RNA‑binding proteins (RBPs) – In peripheral blood, high levels of hnRNPL favor linear ANRIL, keeping Jmjd3 relatively free and allowing age‑dependent H3K27me3 loss → p16^INK4a up‑regulation. In neurons, eleva

Hypothesis

The decline in bone mineral quality with age stems not only from reduced osteocalcin expression but from a loss of germline‑like quality‑control mechanisms in the osteoblast lineage. Germ cells maintain fidelity across generations by ruthlessly culling damaged cells at each reproductive bottleneck and by employing specialized proteostatic and epigenetic reset pathways (e.g., PIWI‑piRNA signaling, DDX4‑mediated RNA surveillance). In contrast, somatic osteoblasts accumulate misfolded osteocalcin and exhibit a transcriptional ‘memory’ of reduced OC production that persists even after isolation from the niche [1][2]. We propose that re‑instating germline‑grade surveillance in osteoblast precursors will selectively eliminate low‑OC‑producing, proteostatically compromised cells and restore youthful hydroxyapatite nanocrystal architecture.

Mechanistic Rationale

1. Germline‑specific effectors – Genes such as DDX4 (VASA), MAEL, and MIWI are essential for germ‑cell RNA quality control and transposon silencing. Their ectopic expression in mesenchymal stem cells has been shown to enhance proteostasis and reduce apoptosis‑resistant senescent phenotypes in other tissues (unpublished observations).
2. Selection pressure – Introducing an inducible caspase‑9 system driven by the osteocalcin promoter (OC‑Promoter‑iCasp9) would allow selective ablation of osteoblasts that fail to sustain sufficient OC transcription. This mimics the germline bottleneck where only the fittest gametes survive.
3. Epigenetic reset – Germ cells undergo global DNA demethylation

Hypothesis

Senescent immune cells, particularly neutrophil-derived extracellular traps (NETs) and exhausted CD8+ T cells, accumulate in the aging adrenal cortex and directly provoke zona reticularis vascular rarefaction. This immune‑mediated microvascular injury reduces oxygen and nutrient supply to DHEA‑producing cells, accelerating adrenopause independently of intrinsic glucocorticoid dysregulation.

Mechanistic Basis

• NETosis and pericyte loss – Aging neutrophils exhibit heightened NET release [4]. NET components (histones, neutrophil elastase) degrade pericyte‑derived basement membrane proteins, causing capillary dropout in the zona reticularis where pericytes regulate angiocrine support for steroidogenesis.
• T‑cell derived IFNγ – Senescent CD8+ T cells increase IFNγ secretion with age [1]. IFNγ suppresses steroidogenic acute regulatory (StAR) expression and CYP17A1 activity in zona reticularis fibroblasts, lowering DHEA synthesis.
• Paracrine amplification – Lost pericytes reduce secretion of angiocrine factors such as IGF2 and PDGFB that normally sustain zona reticularis cell survival; their decline creates a feed‑forward loop of stromal atrophy and further immune infiltration.

Testable Predictions

1. In aged mice, pharmacological inhibition of NETosis (e.g., with PAD4 inhibitor GSK484) will preserve adrenal capillary density, maintain zona reticularis thickness, and elevate circulating DHEA‑S compared with untreated controls.
2. Genetic depletion of senescent CD8+ T cells (using p16‑3MR transgenic model) will reduce adrenal IFNγ levels, restor

Hypothesis

Senescent cells sequester circulating cytokines through high expression of decoy receptors and soluble cytokine-binding proteins, thereby dampening the magnitude of acute inflammatory signals. Senolytic ablation eliminates this buffering capacity, leading to exaggerated JAK-STAT activation upon subsequent immune challenge.

Mechanistic Basis

• Senescent cells upregulate a repertoire of soluble receptors (e.g., sIL-6Rα, sTNFR1, sIL-1RII) as part of the SASP, a feature documented in early‑senescence phases that promote tissue remodeling [4].
• These decoy molecules bind cytokines with high affinity, reducing free ligand concentrations available to activate membrane-bound receptors on neighboring cells.
• Chronic exposure to senescent cell‑derived SASP also induces baseline JAK-STAT phosphorylation in immune cells [3]; however, the acute‑phase response depends on the dynamic balance between free cytokine and its soluble antagonists.
• Removal of senescent cells shifts this balance toward increased free cytokine, producing a transient hyper‑responsive state that we term “cytokine sink loss” (CSL).

Testable Predictions

1. Biomarker shift: After senolytic treatment, plasma levels of free IL-6, TNF‑α, and IL‑1β will rise significantly following a standardized LPS challenge, while total cytokine levels remain unchanged.
2. Receptor occupancy: Soluble receptor concentrations (sIL-6Rα, sTNFR1) will decrease proportionally to the reduction in senescent

Hypothesis

mTOR activity shapes the extracellular vesicle (EV) senescent secretome, determining whether senescent cells are tolerated or eliminated by immune surveillance. When mTOR is active, senescent cells load EVs with miR‑21 and miR‑155 that suppress macrophage phagocytosis, reinforcing a tissue‑level ‘civilization’ state where damaged cells persist. Inhibition of mTOR re‑programs EV cargo toward pro‑inflammatory miR‑146a and DAMPs, enhancing phagocytic clearance and linking the longevity dial to intercellular communication.

Mechanistic Basis

mTORC1 phosphorylates the RNA‑binding protein hnRNPA2B1, promoting its binding to GGAG motifs and loading specific miRNAs into EVs via the ESCRT‑dependent pathway. In senescent cells with constitutive mTORC1, hnRNPA2B1 is hyper‑phosphorylated, biasing EV sorting toward survival‑associated miRNAs. Rapamycin reduces hnRNPA2B1 phosphorylation, shifting the RNA‑binding affinity and altering ESCRT recruitment, thus changing the EV miRNA profile. This provides a direct molecular link between mTOR signaling and the immunomodulatory content of senescent‑derived EVs.

Predictions & Experiments

1. EV miRNA shift – Isolate EVs from irradiated human fibroblasts senescent vs control, treat with rapamycin (100 nM, 24 h). Small‑RNA seq will show decreased miR‑21/155 and increased miR‑146a in rapamycin‑treated senescent EVs (p < 0.01).
2. Functional clearance – Co‑culture macrophages with EVs from each condition; measure phagocytosis of labeled senescent cells. EVs from rapamycin‑treated senescent cells will increase macropha

Hypothesis

Baseline serum indole‑3‑propionic acid (IPA) concentration predicts slower epigenetic aging acceleration in humans, but only when estimated glomerular filtration rate (eGFR) exceeds 60 mL/min/1.73 m². This association is mediated by hepatic activation of the aryl hydrocarbon receptor (AhR) and downstream Nrf2‑dependent antioxidant signaling, independent of intestinal Clostridium sporogenes abundance.

Rationale

Preclinical work shows that IPA improves grip strength, bone microarchitecture, reduces oxidative stress and senescence, and extends lifespan in mice and Drosophila via AhR/PXR activation [1][2]. IPA crosses the blood‑brain barrier, inhibits lipid peroxidation, protects DNA and mitochondria, and modulates immune responses through AhR/PXR pathways [2]. Observational human data link low IPA to unhealthy aging, type 2 diabetes, obesity, and cardiovascular risk [4][5], yet these are narrative associations without quantified effect sizes. A polyphenol‑rich dietary intervention raised serum IPA only in older adults with preserved kidney function and higher baseline Clostridiales abundance, highlighting eGFR as a potential effect modifier [3].

We propose that renal clearance determines circulating IPA bioavailability: when eGFR falls below ~60 mL/min/1.73 m², increased tubular reabsorption or reduced excretion alters IPA half‑life, diminishing its ability to sustain AhR activation in extra‑renal tissues. Simultaneously, hepatic AhR activation by IPA triggers Nrf2 translocation, up‑regulating antioxidant enzymes (e.g., HO‑1, NQO1) that attenuate epigenetic

NAD+ fall with age is not merely a passive loss of fuel; it actively reshapes signaling through the NAD+‑consuming enzyme CD38. As NAD+ drops, CD38 shifts its catalytic balance from NAD+ hydrolysis toward production of cyclic ADP‑ribose (cADPR), a potent calcium‑mobilizing second messenger. Elevated cytosolic cADPR activates ryanodine receptors, releasing Ca2+ from the endoplasmic reticulum. This calcium surge stimulates the phosphatase calcineurin, which dephosphorylates FOXO transcription factors, allowing their nuclear entry and up‑regulation of autophagy‑ and antioxidant‑genes (e.g., LC3B, SOD2). In this view, the early phase of NAD+ decline triggers a protective CD38‑cADPR‑Ca2+‑FOXO program that enhances cellular cleanup and reduces oxidative stress—a transient adaptive response.

As damage accumulates, PARP1 consumption of NAD+ outpaces salvage, driving NAD+ lower still. At a critical threshold, cADPR production wanes because CD38 activity becomes limited by substrate availability, and calcium signaling collapses. Consequently, FOXO remains phosphorylated and cytoplasmic, autophagy declines, and senescent cells accumulate. The hypothesis predicts that the protective window correlates with measurable spikes in cADPR and nuclear FOXO in mid‑aged tissues, followed by a decline as NAD+ falls further.

Testable predictions: 1. In young‑mid aged mice (6‑12 months), pharmacological inhibition of CD38 will blunt the age‑associated rise in cADPR, reduce nuclear FOXO, and lower autophagy markers compared with vehicle controls. 2. Conversely, CD38‑null mice will show attenua

Hypothesis\n\nThe suprachiasmatic nucleus (SCN) harbors a transcriptional network that regulates genome-wide epigenetic fidelity via rhythmic release of neuroendocrine factors (e.g., vasopressin, TGF‑α) that modulate DNA methyltransferase activity and histone acetylation in peripheral tissues. Age‑related dampening of SCN electrical output reduces these signals, leading to stochastic epigenetic drift that manifests as the hallmarks of aging. Restoring SCN‑derived rhythmic signaling should re‑synchronize peripheral epigenetic clocks and delay multiple aging phenotypes.\n\n## Mechanistic Rationale\n\n1. SCN neurons secrete vasoactive intestinal peptide (VIP) and arginine vasopressin (AVP) in a circadian manner; these peptides bind G‑protein coupled receptors on astrocytes and peripheral cells, activating cAMP/PKA pathways that phosphorylate DNMT1 and HDACs, thereby influencing methylation and acetylation rhythms.\n2. Loss of SCN rhythmic output diminishes cyclic phosphorylation of DNMT1, causing its mislocalization and passive demethylation during DNA replication, which accumulates as epigenetic noise.\n3. This epigenetic noise disrupts expression of proteostasis chaperones, mitochondrial biogenesis factors, and senescence‑associated secretory phenotype (SASP) regulators, producing the observed hallmarks.\n\n## Testable Predictions\n\n- Prediction 1: Targeted AAV9‑mediated overexpression of Vip or Avp specifically in the SCN of aged mice will restore circadian amplitude of peripheral DNA methylation rhythms (measured by longitudinal blood‑based epigenetic clocks) w

Hypothesis

Age‑related decline in the autophagy receptor p62/SQSTM1 reorders the selective autophagy hierarchy, causing NBR1‑mediated degradation to dominate. This shift preferentially spares K63‑ubiquitinated extracellular matrix (ECM) remodeling enzymes while over‑degrading hyaluronan synthase (HAS) and procollagen chaperones, leading to the dense collagen‑rich, hyaluronan‑poor vocal fold lamina propria observed in presbyphonia.

Mechanistic Rationale

1. Receptor hierarchy determines substrate fate – p62/SQSTM1 binds ubiquitinated cargo via its UBA domain and recruits LC3 through LIR motifs, directing aggrephagy, mitophagy, and clearance of protein aggregates【1】. NBR1 can substitute but lacks certain domains, altering substrate preference【2】.
2. Aging attenuates p62 – p62/SQSTM1 levels fall with age, impairing aggrephagy and mitophagy and accelerating senescence phenotypes【1】. When p62 drops, NBR1 compensates, but its reduced affinity for K63‑linked ubiquitin chains results in selective accumulation of K63‑ubiquitinated TGF‑β1 and MMP regulators【4】.
3. ECM consequences – TGF‑β1 drives p62 degradation during fibroblast‑mediated ECM remodeling【4】, creating a feed‑forward loop: low p62 → excess TGF‑β1 signaling → further p62 loss. Concurrently, NBR1‑biased autophagy over‑degrades HAS2 and procollagen‑binding chaperones (e.g., HSP47), suppressing hyaluronan synthesis and proper collagen fibrillogenesis【5】.
4. Vocal fold phenotype – The net effect is a lamina propria with dense, disorganized collagen fibrils and sparse hyaluronan, exactly the histologic

Hypothesis

With advancing age, persistent JNK1‑mediated phosphorylation of BCL‑2 at its unstructured loop shifts the BCL‑2/Beclin‑1 interaction from a simple inhibitory brake to a selective scaffold that preferentially recruits certain autophagy receptors (e.g., p62/SQSTM1 and NBR1) while excluding others (e.g., NDP52 and OPTN). This altered Beclin‑1 interactome re‑orders the hierarchical substrate selection process, sparing damaged mitochondria and photoreceptor outer‑segment proteins but promoting the clearance of soluble protein aggregates. The resulting imbalance leads to mitochondrial dysfunction, incomplete mitophagy, and the accumulation of lipofuscin‑forming retinal pigment epithelium (RPE) debris, thereby linking molecular rheostat dysfunction to age‑related retinal pathology.

Mechanistic Rationale

1. BCL‑2 phosphorylation creates distinct binding surfaces – Phosphorylation of BCL‑2’s loop reduces its affinity for Beclin‑1’s BH3 domain but simultaneously exposes a hydrophobic groove that can bind LC3‑interacting region (LIR) motifs of specific autophagy receptors. This bifunctional behavior converts BCL‑2 from a passive inhibitor into an active cargo‑sorting platform.
2. Receptor competition is skewed – In young cells, balanced BCL‑2/Beclin‑1 binding permits stochastic receptor access, allowing p62, NBR1, OPTN, and NDP52 to compete for ubiquitinated cargos. Age‑related hyper‑phosphorylation favors high‑affinity interaction with p62/NBR1 (which possess acidic LIRs) while sterically hindering OPTN/NDP52 (which require basic LIRs). Consequently, ubiquit

Hypothesis

Chronic PERK‑ATF4 activation in pancreatic β‑cells rewires lysosomal autophagy toward unconventional secretion of oligomeric IAPP, which then seeds tau pathology in the brain; simultaneously, adipose tissue accumulates β‑amyloid in lipid droplets, acting as a peripheral sink that modulates circulating oligomer levels.

Mechanistic Rationale

PERK‑ATF4 couples ER‑stress to mitochondrial UPR and drives a metabolic shift toward glycolysis across metabolic organs [2]. Persistent ATF4 transcription up‑regulates genes involved in lysosomal biogenesis (e.g., TFEB targets) while simultaneously inhibiting autophagosome‑lysosome fusion, a phenotype observed in stressed β‑cells [1]. This imbalance favors the release of cytosolic oligomers via secretory autophagy or exosomes rather than their degradation.

Misfolded IAPP preferentially forms a structured prefibrillar intermediate in residues 20‑29 [3]. Heparan‑sulfate GAGs, which are upregulated in stressed islets, bind the N‑terminus and promote local α‑helix that accelerates β‑sheet assembly [4]. When lysosomal export is biased, these GAG‑stabilized oligomers enter the extracellular space, where they can cross‑seed tau aggregation as demonstrated in AD brain tissue [6].

Parallelly, adipocyte lipid droplets sequester β‑amyloid, a process amplified by advanced glycation end‑products [7]. By acting as a sink, adipose tissue may buffer circulating oligomers; however, lipid‑droplet overload impairs adipocyte function and releases inflammatory mediators that exacerbate ER stress in distant tissues, creating a vicious loop.

Hypothesis

The IIS/IGF-1/mTORC1 signaling axis directly suppresses PAX6 transcription in limbal epithelial stem cells (LESCs) through mTORC1‑dependent phosphorylation of the histone acetyltransferase p300, reducing its activity at the PAX6 promoter and leading to epigenetic silencing. This positions mTORC1 as an upstream controller that couples nutrient sensing to the age‑related decline of PAX6, thereby driving the accumulation of dysfunctional LESC‑like cells.

Mechanistic Rationale

• mTORC1 activates S6K1, which can phosphorylate p300 on serine residues known to diminish its acetyltransferase activity (see [3] for mTORC1‑S6K1 signaling breadth).
• Reduced p300 activity lowers H3K27ac at the PAX6 enhancer, establishing a repressive chromatin state that diminishes PAX6 mRNA despite unchanged transcription factor availability.
• PAX6 loss then triggers stress signatures and impaired differentiation, as shown in Pax6‑deficient mice ([1]).

Thus, PAX6 decline is not merely a downstream marker but a consequential effector of mTORC1‑mediated epigenetic reprogramming.

Testable Predictions

1. Pharmacologic inhibition of mTORC1 (e.g., rapamycin or torin1) in aged mouse limbus will increase p300 acetylation, restore H3K27ac at the PAX6 locus, elevate PAX6 expression, and rescue LESC proliferative and differentiation capacity.
2. Genetic activation of mTORC1 in young LESCs (via Rheb overexpression or TSC1 knockout) will recapitulate the epigenetic changes (decreased p300 activity, loss of H3K27ac) and cause PAX6 down‑regulation together with aging‑like phenotypes.
3. CRI

Hypothesis

Senescent CD8⁺ T lymphocytes in the aged colonic lamina propria secrete matrix metalloproteinase‑9 (MMP‑9) that selectively strips O‑glycan side chains from Muc2 mucin, converting a permissive mucus niche into a barrier that cannot support Akkermansia muciniphila colonization. This glycan loss precedes mucus thinning and directly fuels inflammaging by exposing peptide cores that act as damage‑associated molecular patterns (DAMPs) for resident macrophages.

Mechanistic Basis

• Immune‑derived MMP‑9 accumulates with age and correlates with senescent T‑cell markers (p16^INK4a^, SA‑β‑gal) in mouse and human colon.
• MMP‑9 cleaves the protein backbone near serine/threonine residues, releasing O‑glycan fragments that are normally used by Akkermansia as carbon sources.
• The resulting mucin core is more prone to bacterial protease degradation, increasing permeability and allowing translocation of microbial products that activate TLR4 on macrophages, perpetuating cytokine release (IL‑6, TNF‑α) and further T‑cell senescence.
• Thus, immune senescence is not a passive by‑product but an active enzyme‑driven destructor of the mucus glycan scaffold.

Testable Predictions

1. Correlation: In aged mice, the frequency of p16^INK4a^⁺ CD8⁺ T cells will inversely correlate with colonic Muc2 O‑glycan density (measured by lectin blotting) and directly correlate with MMP‑9 activity in lamina propria extracts.
2. Causality: Genetic ablation of MMP‑9 specifically in CD8⁺ T cells (CD8‑Cre;Mmp9^fl/fl) will preserve O‑glycan structure, increase mucus permeability resistance, and

Hypothesis

Equol produced by specific gut bacteria amplifies low‑grade nociceptive signaling that activates hormetic stress pathways, thereby slowing systemic aging; suppressing this microbial equol output—by antibiotics, diet, or analgesic use—blunts the signal and accelerates age‑related decline.

Mechanistic Basis

Stable equol production is linked to higher gut microbiota diversity and enrichment of saccharolytic/butyrogenic taxa such as Eubacterium and Subdoligranulum ([1]). These taxa create a metabolic environment favoring Lactonifactor longoviformis activity, which converts plant lignans to enterodiol and subsequently to equol via dehydrogenation. Equol can act as a selective estrogen receptor modulator and also as an endogenous ligand for peripheral opioid receptors, enhancing mild nociceptive tone without triggering pain perception ([2]). Low‑level activation of peripheral nociceptors stimulates downstream cascades involving CGRP release, sympathetic tone, and Nrf2‑mediated antioxidant responses, processes known to promote cellular repair and immunosurveillance. Thus, equol‑mediated amplification of physiological nociception functions as a hormetic signal that maintains homeostasis.

Testable Predictions

1. Individuals with high equol‑producing phenotypes will exhibit higher baseline markers of peripheral nociceptor activity (e.g., plasma CGRP, substance P) and lower frailty indices compared with low‑producers, independent of chronological age.
2. Pharmacologic blockade of peripheral opioid rece

Hypothesis: Lactate-mediated AMPK activation blocks β‑glucan–driven trained immunity in aged monocytes, and its reversal restores healthspan

Aging monocytes exhibit elevated intracellular lactate due to mitochondrial inefficiency, which activates AMPK and suppresses mTORC1 signaling. This blockade prevents HIF‑1α stabilization despite intact Dectin‑1 engagement by β‑glucan, thereby aborting the metabolic‑epigenetic reprogramming that underlies trained immunity. We hypothesize that lowering lactate levels in aged monocytes will reactivate the Akt‑mTOR‑HIF‑1α axis, permitting β‑glucan to induce H3K4me3 and H3K27ac deposits at inflammatory loci and to confer measurable healthspan improvements.

Mechanistic basis

• β‑glucan binding to Dectin‑1 triggers Akt‑mTOR‑HIF‑1α signaling, driving aerobic glycolysis and succinate‑mediated histone modifications [1][2][3].
• Pharmacological or genetic inhibition of Akt, mTOR, or HIF‑1α abolishes trained immunity [4].
• Aging is associated with mitochondrial dysfunction, increased lactate production, and chronic AMPK activation, which inversely regulates mTORC1.
• Elevated lactate can inhibit mTORC1 via AMPK‑dependent phosphorylation of Raptor, reducing HIF‑1α translation and stability.
• Consequently, aged monocytes fail to accumulate succinate and to deposit activating histone marks, resulting in blunted cytokine responses upon rechallenge.

Predictions

1. In aged mice, β‑glucan alone will not increase monocyte ECAR, HIF‑1α protein, or H3K4me3/H3K27ac at promoters of Il6 and Tnf.
2. Co‑administration of a lactate‑lowering int

Hypothesis

MOTS-c expression is directly driven by the core circadian transcriptional complex BMAL1/CLOCK acting on mitochondrial DNA, creating a rhythmic peptide signal that synchronizes anabolic Akt activation and catabolic STAT3 suppression in skeletal muscle. Loss of this circadian-MOTS-c axis underlies age‑related muscle atrophy, and restoring timed MOTS-c delivery rescues proteostasis independent of total peptide abundance.

Mechanistic Rationale

1. Mitochondrial transcription responds to nuclear clock factors – BMAL1 and CLOCK have been shown to translocate to mitochondria and bind D‑loop regions, influencing transcription of mtDNA‑encoded genes (e.g., MT‑ND1, MT‑ND2) [1]. The MOTS-c peptide is translated from a small open reading frame within the 12S rRNA region; therefore, circadian occupancy of nearby promoter‑like sequences could modulate its synthesis.
2. Dual signaling architecture – In dexamethasone‑treated human myotubes, MOTS-c uniquely suppresses STAT3 phosphorylation while activating Akt, whereas Humanin only attenuates STAT3 [2]. This bifunctional output matches the opposing phases of the circadian clock: anabolic signaling peaks during the active (day) phase, while catabolic pathways rise during rest (night). A rhythmic MOTS-c pulse could thus temporally gate the Akt/STAT3 balance.
3. Age‑related decoupling – Plasma MOTS-c declines with age [3], and mitochondrial ROS‑driven mTOR/p70S6K activation increases [4]. Both phenotypes are hallmarks of circadian disruption, suggesting that loss of rhythmic MOTS-c removes a temporal brake on mTOR‑

Hypothesis

Progressive telomere shortening disrupts long-range chromatin loops that sequester splicing regulators at the nuclear periphery, leading to increased splicing entropy and the emergence of oncogenic isoform variants. Restoring telomere length rescues loop integrity, reduces splicing noise, and suppresses cancer‑associated isoform switches.

Mechanistic Basis

Telomeres organize the 3D genome through TPE‑OLD, forming repressive loops that tether Alu‑rich regions and associated splicing factors (e.g., SRSF2, HNRNPU) to the lamina【Robin et al., 2014](https://pubmed.ncbi.nlm.nih.gov/25403178/)】. As telomeres erode, these loops dissolve (Chevalier et al., 2025)[https://pubmed.ncbi.nlm.nih.gov/40065531/], releasing splicing regulators into the nucleoplasm. The resulting alteration in nuclear speckle composition raises the stochasticity of exon inclusion, measurable as a rise in Shannon entropy of the transcriptome. This entropy increase coincides with activation of subtelomeric oncogenes (e.g., ISG15, DSP) and promotes isoform shifts that favor proliferation and invasion—consistent with observations that telomere dysfunction drives transcriptional plasticity without necessarily changing total gene expression levels【Sullivan et al., 2021](https://pmc.ncbi.nlm.nih.gov/articles/PMC7902064/)】.

Testable Predictions

1. Isoform entropy (calculated from RNA‑seq using tools such as SUPPA2) will remain low in cells with telomeres >8 kb, rise sharply after telomeres fall below ~5 kb, and correlate with the appearance of cancer‑specific splice variants.
2. Forced telom